Overview
Despite their usefulness in perioperative and acute care settings, factor-Xa inhibitors-specific assays are scarcely available, contrary to heparin anti-Xa assay. The investigators aimed at assessing whether the widely used heparin anti-Xa assay can quantify the apixaban, rivaroxaban, fondaparinux and danaparoid levels.
Eligibility
Inclusion Criteria :
- Blood sample from adult patients treated with apixaban or rivaroxaban or danaparoid or fondaparinux
Exclusion Criteria :
- Patients treated with unfractionated heparin or low molecular weight heparin